Mumbai has reported its first case of Guillain-Barre Syndrome (GBS), a rare neurological disorder where the immune system ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

The nervous system is a central component of the human body, but most people don't spend much time thinking about it.

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...